{{Redirect|Americaine|other uses|Americain (disambiguation)}}
{{Use mdy dates|date=March 2014}}
{{Drugbox
| Watchedfields = changed
| verifiedrevid = 457480862
| IUPAC_name = Ethyl 4-aminobenzoate
| image = Benzokaina.svg
| width = 235px
| image2 = Benzocaine-from-xtal-3D-balls.png
| width2 = 225px
<!--Clinical data-->
| Drugs.com = {{Drugs.com|monograph|benzocaine-topical}}
| tradename = Anbesol, Cepacol, Lanacane, Orajel, Anesthesin<ref>https://pubchem.ncbi.nlm.nih.gov/compound/benzocaine#section=Depositor-Supplied-Synonyms</ref>, 
| pregnancy_US = C
| routes_of_administration = [[Topical medication|Topical]]
| legal_US = OTC
| legal_UK = GSL
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 94-09-7
| ATC_prefix = C05
| ATC_suffix = AD03
| ATC_supplemental = {{ATC|D04|AB04}}, {{ATCvet|N01|AX92}}, {{ATC|N01|BA05}}, {{ATC|R02|AD01}}
| PubChem = 2337
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01086
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 13854242
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = U3RSY48JW5
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00552
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 116735
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 278172
<!--Chemical data-->
| C=9 | H=11 | N=1 | O=2
| molecular_weight = 165.189 g/mol
| SMILES = O=C(OCC)c1ccc(N)cc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BLFLLBZGZJTVJG-UHFFFAOYSA-N
}}

'''Benzocaine''', sold under the brand name '''Orajel''' among others, is a [[local anesthetic]] commonly used as a [[topical]] [[analgesic|pain reliever]] or in [[cough drop]]s. It is the [[active ingredient]] in many [[over-the-counter]] [[anesthetic]] [[ointment]]s such as products for [[oral ulcer]]s. It is also combined with [[antipyrine]] to form [[antipyrine and benzocaine ear drops|A/B otic drops]] to relieve [[ear pain]] and remove [[earwax]].

==Medical uses==
Benzocaine is indicated to treat a variety of [[pain]]-related conditions. It may be used for:

* Local anesthesia of oral and pharyngeal mucous membranes (sore throat, cold sores, mouth ulcers, toothache, sore gums, denture irritation)<ref name="ReferenceA">AHFS Drug Information 2007. McEvoy GK, ed. Benzocaine. Bethesda, MD: American Society of Health-System Pharmacists; 2007: 2844-5.</ref>
* Otic pain (earache)<ref name="ReferenceA" />
* Surgical or procedural local anesthesia<ref>Sultan Healthcare. Topex®metered spray (benzocaine 20%) prescribing information. Englewood, NJ; 2006.</ref>

===Other uses===
[[File:Jiffy Toothache Drops bottle.jpg|thumb|upright|right|Jiffy Toothache Drops bottle (7.75% Benzocaine)]]

Benzocaine is used as a key ingredient in numerous pharmaceuticals:

* Some glycerol-based ear medications for use in removing excess wax as well as relieving ear conditions such as ''[[otitis media]]'' and [[Otitis externa|swimmers ear]].
* Some previous diet products such as [[Ayds]].
* Some [[condoms]] designed to prevent [[premature ejaculation]]. Benzocaine largely inhibits sensitivity on the [[penis]], and can allow for an [[erection]] to be maintained longer (in a continuous act) by delaying ejaculation. Conversely, an erection will also fade faster if stimulus is interrupted.<ref>{{cite news| url=http://news.bbc.co.uk/1/hi/health/2049202.stm | work=BBC News | title='Longer-lasting' condom launched | date=June 17, 2002}}</ref><ref>{{cite news| url=https://www.nytimes.com/2002/12/15/magazine/15ENDU.html | work=The New York Times | first=Dwight | last=Garner | title=Endurance Condoms | date=December 15, 2002}}</ref>
* Benzocaine mucoadhesive patches have been used in reducing orthodontic pain.<ref>{{cite journal |vauthors=Eslamian L, Borzabadi-Farahani A, Edini HZ, Badiee MR, Lynch E, Mortazavi A |title= The analgesic effect of benzocaine mucoadhesive patches on orthodontic pain caused by elastomeric separators, a preliminary study.|journal= Acta Odontol Scand|volume=71 |issue=5 |pages=1168–73 |year=2013 |pmid= 23301559 |doi= 10.3109/00016357.2012.757358}}</ref>
* In Poland it is included, together with menthol and zinc oxide, in the liquid powder (not to be confused with the liquid [[face powder]]) used mainly after mosquito stings. Today's ready made Pudroderm<ref>{{cite web|title=Produkty {{!}} PUDRODERM|url=http://www.pampa.com.pl/page.php?cat=produkty&doc=pudroderm|accessdate=9 May 2014|language=pl}}</ref> was once used there as [[compounding|pharmaceutical compound]].

===Available forms===
Benzocaine can come in a variety of preparations including:

Oral preparations:

* Lozenges (ex. [[Cepacol]], Mycinettes)<ref>{{cite web|url=http://www.cepacol.com/?gclid=CPbV09uQ1sECFU9efgodWT0AsQ&gclsrc=aw.ds |title=Cepacol® |publisher=Cepacol.com |date= |accessdate=2015-06-02}}</ref>
Topical preparations:
* Aerosol (ex. Topex)<ref>{{cite web|url=http://www.sultanhc.com/sw/swchannel/productcatalogcf_v2/internet/model.asp?ProductMasterID=285313&ParentID=215728&SWID=1 |title=Topex® Metered Spray-Sultan Healthcare |publisher=Sultanhc.com |date= |accessdate=2015-06-02}}</ref>
* Gel (ex. Orajel)<ref>{{cite web|url=http://www.orajel.com/ |title=Orajel™ - Oral Care for the Whole Family |publisher=Orajel.com |date=2015-05-11 |accessdate=2015-06-02}}</ref>
* Paste (ex. Orabase)<ref>{{cite web|url=http://www.colgateprofessional.com/products/colgate-orabase-paste-with-benzocaine/overview |title=Colgate Orabase Paste with Benzocaine &#124; Indications &#124; Dental Products |publisher=Colgateprofessional.com |date= |accessdate=2015-06-02}}</ref>
Otic preparations:
* Solution (ex. Allergen)<ref>{{cite web|url=http://www.everydayhealth.com/drugs/antipyrine-benzocaine-otic |title=Antipyrine Benzocaine Otic – Side Effects, Dosage, Interactions |publisher=Everyday Health |date=2015-03-18 |accessdate=2015-06-02}}</ref>

==Side effects==
Benzocaine is generally well-tolerated and non-toxic when applied topically as recommended.<ref>Lexicomp Online, Adult and Pediatric Lexi-Drugs Online, Hudson, Ohio: Lexi-Comp, Inc.; 2013; April 15, 2013.</ref>

However, there have been reports of serious, life-threatening adverse effects (e.g., seizures, coma, irregular heart beat, respiratory depression) with over-application of topical products or when applying topical products that contain high concentrations of benzocaine to the skin.<ref>Food and Drug Administration. FDA Public Health Advisory: Life-threatening side effects with use of skin products containing numbing ingredients for cosmetic procedures. 2007 Feb 6, updated 2007 Feb 9. From FDA website</ref>

Overapplication of oral anesthetics such as benzocaine can increase the risk of [[pulmonary aspiration]] by relaxing the gag-reflex and allowing regurgitated stomach contents or oral secretions to enter the airway. Applying an oral anesthetic and consuming beverages before going to bed can be particularly hazardous.

The topical use of higher concentration (14-20%) benzocaine spray products applied to the mouth or mucous membranes has been found to be a cause of [[methemoglobinemia]], a disorder in which the amount of oxygen carried by the blood is greatly reduced.<ref>{{cite journal |pmid=7730550 |year=1995 |author1=Shua-Haim |first1=J. R. |title=Methemoglobinemia toxicity from topical benzocaine spray |journal=Journal of the American Geriatrics Society |volume=43 |issue=5 |pages=590 |last2=Gross |first2=J. S. |doi=10.1111/j.1532-5415.1995.tb06117.x}}</ref> This side effect is most common in children under 2 years of age.<ref>{{cite web|url=http://www.drugs.com/fda/benzocaine-topical-products-gels-liquids-risk-methemoglobinemia-12941.html |title=Benzocaine Topical Products: Sprays, Gels and Liquids – Risk of Methemoglobinemia |publisher=Drugs.com |date= |accessdate=March 20, 2014}}</ref> As a result, the FDA has stated that benzocaine products should not be used in children under 2 years of age, unless directed by and supervised by a healthcare professional.<ref name="fda.gov">{{cite web|author= |url=http://www.fda.gov/drugs/drugsafety/ucm250024.htm#safety |title=FDA Drug Safety Communication: Reports of a rare, but serious and potentially fatal adverse effect with the use of over-the-counter (OTC) benzocaine gels and liquids applied to the gums or mouth |publisher=Fda.gov |date= |accessdate=2015-06-02}}</ref> Symptoms of methemoglobinemia usually occur within minutes to hours of applying benzocaine, and can occur upon the first-time use or after additional use.<ref name="fda.gov" />

Benzocaine may cause allergic reactions.<ref>{{cite web|url=http://www.bedfordhospital.nhs.uk/upload_folder/patient%20information/allergy%20to%20benzocaine.pdf|title=Allergy to Benzocaine|publisher=|date=|accessdate=March 20, 2014|deadurl=yes|archiveurl=https://web.archive.org/web/20140320095658/http://www.bedfordhospital.nhs.uk/upload_folder/patient%20information/allergy%20to%20benzocaine.pdf|archivedate=March 20, 2014|df=mdy-all}}</ref><ref>{{Cite journal|pmid=10357712 |year = 1999|author1 = Sidhu|first1 = S. K.|title = A 10-year retrospective study on benzocaine allergy in the United Kingdom|journal = American Journal of Contact Dermatitis|volume = 10|issue = 2|pages = 57–61|last2 = Shaw|first2 = S|last3 = Wilkinson|first3 = J. D.|doi=10.1016/s1046-199x(99)90000-3}}</ref><ref>{{cite journal |pmid=22551703|url=http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90193182&pident_usuario=0&pcontactid=&pident_revista=403&ty=87&accion=L&origen=cardio&web=http://www.revespcardiol.org&lan=en&fichero=403v104n02a90193182pdf001.pdf |title= Allergic contact dermatitis to benzocaine: The importance of concomitant positive patch test results|journal=Actas Dermo-Sifiliográficas |volume=104 |issue=2 |pages=156–8 |publisher= |date= |accessdate=March 20, 2014|year=2013 |author1=González-Rodríguez |first1=A. J. |last2=Gutiérrez-Paredes |first2=E. M. |last3=Revert Fernández |first3=Á. |last4=Jordá-Cuevas |first4=E |doi=10.1016/j.ad.2011.07.023 }}</ref><ref>{{cite news|author= Leslie Goldman |url=http://www.cnn.com/2008/HEALTH/02/05/healthmag.creams/index.html?iref=newssearch |title=Go easy on medicated lotions, creams, gels |publisher=CNN |date=February 5, 2008 |accessdate=March 20, 2014}}</ref> These include:
* Contact dermatitis (redness and itchiness)<ref name="ReferenceB">Cetylite Industries. Cetacaine® (benzocaine 14%, tetracaine 2% and butamben 2%) spray, gel and liquid prescribing information. Pennsauken, NJ; 2006 Sept.</ref>
* Anaphylaxis (rare)<ref name="ReferenceB" />

==Pharmacology==

===Pharmacodynamics===
[[Pain]] is caused by the stimulation of [[free nerve ending]]s. When the [[nerve ending]]s are stimulated, [[sodium]] enters the [[neuron]], causing [[depolarization]] of the [[nerve]] and subsequent initiation of an [[action potential]]. The action potential is propagated down the nerve toward the [[central nervous system]], which interprets this as pain. Benzocaine acts to [[channel blocker|inhibit]] the [[voltage-dependent sodium channel]]s (VDSCs) on the [[neuron]] [[cell membrane|membrane]], stopping the propagation of the action potential.

==Chemistry==
Benzocaine is the [[ethyl group|ethyl]] [[ester]] of [[para-Aminobenzoic acid|''p''-aminobenzoic acid]] (PABA). It can be prepared from PABA and [[ethanol]]<ref>{{cite journal | doi = 10.1021/ed100838a | title = Synthesis of Two Local Anesthetics from Toluene: An Organic Multistep Synthesis in a Project-Oriented Laboratory Course | year = 2012 | last1 = Demare | first1 = Patricia | last2 = Regla | first2 = Ignacio | journal = Journal of Chemical Education | volume = 89 | page = 147}}</ref> by [[Fischer esterification]] or via the reduction of ethyl ''p''-nitrobenzoate. Benzocaine is sparingly soluble in water; it is more soluble in dilute acids and very soluble in ethanol, [[chloroform]] and [[ethyl ether]]. The [[melting point]] of benzocaine is 88–90&nbsp;°C,<ref name=intpharm>{{cite web|url=http://apps.who.int/phint/en/d/Jb.6.1.62/#docfirsthighlight|title=Monographs: Pharmaceutical substances: Benzocainum – Benzocaine|publisher=The International Pharmacopoeia|accessdate=September 29, 2009}}</ref> and the [[boiling point]] is about 310&nbsp;°C.<ref>D'Ans-Lax, Taschenbuch für Chemiker und Physiker, 4. Auflage, Band 2, Springer Verlag 1982, {{ISBN|3-540-12263-X}}</ref> The [[density]] of benzocaine is 1.17&nbsp;g/cm<sup>3</sup>.

Benzocaine is commonly found, particularly in Britain, as an impurity in street [[cocaine]] and also as a bulking agent in "legal highs".<ref>http://www.bbc.co.uk/news/uk-10909884</ref> Whilst giving a numbing effect similar to cocaine on users' gums it does not actually produce the effects of cocaine.<ref>{{cite news| url = http://www.economist.com/node/21560270?fsrc=scn/tw_ec/all_cut_up | title = Drug prices: All cut up : Cocaine is cheaper, but weaker | publisher = ''[[The Economist]]'' | date = August 11, 2012}}</ref> Benzocaine was used in synthesis of [[leteprinim]]. Treatment of benzocaine with hydrazine leads to [[aminostimil]], a compound called related to [[isoniazid]].

===Synthesis===
Benzocaine can be prepared by [[esterification]] using [[4-aminobenzoic acid]] and [[ethanol]].<ref>{{Cite journal | doi = 10.1002/cber.189502802150| title = Ueber Esterbildung bei aromatischen Amidosäuren| journal = Berichte der deutschen chemischen Gesellschaft| volume = 28| issue = 2| pages = 1917| year = 1895| last1 = Salkowski | first1 = H.}}</ref><ref>{{Cite journal | doi = 10.1002/jlac.18651350202| title = Ueber das durch Einwirkung von Jodwasserstoff auf Mannit beziehungsweise auf Melampyrin (Dulcit) entstehende β Hexyljodür und einige seiner Derivate| journal = Annalen der Chemie und Pharmacie| volume = 135| issue = 2| pages = 129| year = 1865| last1 = Erlenmeyer | first1 = E.| last2 = Wanklyn | first2 = J. A.}}</ref> It can also be prepared by reduction of ethyl 4-nitrobenzoate to the [[amine]].<ref>{{Cite journal | doi = 10.1002/jlac.18983030303| title = Ueber die Verbindungen aus Benzoylchlorid oder Phtalylchlorid und den Estern der drei Oxybenzoësäuren| journal = Justus Liebig's Annalen der Chemie| volume = 303| issue = 3| pages = 274| year = 1898| last1 = Limpricht | first1 = H.}}</ref><ref>{{OrgSynth |author=Adams, Roger |author2=Cohen, F.L. |last-author-amp=yes |year=1928 |title=Ethyl ''p''-aminobenzoate |volume=8 |pages=66 |collvol=1 |collvolpages=240 |prep=CV1P0240}}</ref> In industrial practice, the reducing agent is usually iron and water in the presence of a little acid.<ref>{{Cite journal | doi = 10.1016/S0099-5428(08)60164-1| title = Benzocaine| volume = 12| pages = 73| series = Analytical Profiles of Drug Substances| year = 1983| last1 = Ali | first1 = S. L. | isbn = 978-0-12-260812-4}}</ref>

==History==
Benzocaine was first synthesized in 1890 by the German chemist Eduard Ritsert (1859–1946),<ref>Biography of Eduard Ritsert (in German): [http://www.deutsche-biographie.de/sfz106040.html ''Deutsche Biographie'': Ritsert, ''Eduard'' .]</ref> in the town of [[Eberbach (Baden)|Eberbach]]<ref>{{cite web|url=http://www.ritsert.de/index.php?option=com_content&task=view&lang=en&id=13&Itemid=27|title=100 years of Dr. Ritsert |publisher=Dr. Ritsert Pharma|accessdate=March 14, 2010}}</ref> and introduced to the market in 1902 under the name "Anästhesin".<ref>Harry Auterhoff, ''Lehrbuch der pharmazeutischen Chemie'' (Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft, 1968).</ref><ref>Ritsert, E. (1925) "Über den Werdegang des Anästhesins" (On the development of Anästhesin), ''Pharmazeutische Zeitung'', vol. 60, pages 1006–1008. See also: Christoph Friedrich and Magdalena Klimonow, [http://www.pharmazeutische-zeitung.de/index.php?id=31537 "150. Geburtstag: Eduard Ritsert und das Anaesthesin"] (150th birthday: Eduard Ritsert and Anästhetsin [Benzocaine]"), ''Pharmazeutische Zeitung online''. First published clinical study demonstrating the efficacy of benzocaine: Noorden, C. v. (1902) "Ueber para-Aminobenzoesäure-Ester als locales Anästhetikum" (On [an] ester of para-aminobenzoic acid as a local anaesthetic), ''Klinische Wochenschrift'', vol. 39, pages 373–375.</ref>

==Veterinary medicine==
A bath solution of benzocaine has been used to anesthetize [[amphibians]] for surgery.<ref>{{cite journal|last1=Guénette|first1=SA|last2=Giroux|first2=MC|last3=Vachon|first3=P|title=Pain perception and anaesthesia in research frogs.|journal=Experimental Animals|date=2013|volume=62|issue=2|pages=87–92|doi=10.1538/expanim.62.87|pmid=23615302|url=https://www.jstage.jst.go.jp/article/expanim/62/2/62_12-0070/_pdf}}</ref><ref>{{cite web|title=Amphibian Anesthesia — Research at Penn State|url=http://www.research.psu.edu/arp/anesthesia/amphibian-anesthesia.html|website=PennState Animal Resource Program|publisher=The Pennsylvania State University|accessdate=24 August 2017|location=State College, U.S.|language=en|date=8 November 2010}}</ref>

==References==
{{Reflist|30em}}

==External links==
* [http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforheathcareprofessionals/publichealthadvisories/ucm124350.htm Public Health Advisory: Benzocaine Sprays] by the [[Food and Drug Administration]]

{{Local anesthetics}}
{{Throat preparations}}
{{Vasoprotectives}}
{{Antipruritics}}
{{Ion channel modulators}}

[[Category:Benzoates]]
[[Category:Ethyl esters]]
[[Category:Local anesthetics]]
[[Category:Sodium channel blockers]]
[[Category:Wyeth]]